Related Experiment Video
Updated: Jul 1, 2025

09:09
Layer-by-layer Synthesis and Transfer of Freestanding Conjugated Microporous Polymer Nanomembranes
Published on: December 15, 2015
9.4K
Mesoporous nanoperforators as membranolytic agents via nano- and molecular-scale multi-patterning
Yannan Yang1,2,3, Shiwei Chen4, Min Zhang5
1Institute of Optoelectronics, Fudan University, Shanghai, 200433, China. yannan_yang@fudan.edu.cn.
Nature Communications
|February 29, 2024
Summary
Researchers developed novel mesoporous membranolytic nanoperforators (MLNPs) for cancer therapy. These nanostructures effectively lyse cancer cell membranes, showing promising anticancer activity in preclinical models.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Research
Background:
- Plasma membrane lysis is a key anticancer strategy, typically using soluble agents.
- Nanomaterial applications in membranolysis remain largely unexplored.
Purpose of the Study:
- To introduce novel mesoporous membranolytic nanoperforators (MLNPs) for cancer therapy.
- To investigate the nano- and molecular-scale patterning of MLNPs for enhanced membranolytic activity.
Main Methods:
- Fabrication of MLNPs using a nano- and molecular-scale multi-patterning strategy.
- Utilizing computational modeling to understand nanospike-mediated membrane perforation and molecular interactions.
- In vivo testing of MLNPs' anticancer efficacy in mouse models.
Main Results:
- MLNPs exhibit intrinsic membranolytic activity due to their spiky surface topography and ordered organosilica composition.
- Computational modeling revealed multivalent perforation behavior and optimal binding of benzene groups to phospholipids.
- Demonstrated significant antitumour activity of MLNPs in preclinical mouse models.
Conclusions:
- Organosilica-based bioactive nanostructures can be assembled for effective cancer therapy.
- Nano-/molecular patterns play a crucial role in governing nano-bio interactions for membranolysis.
- MLNPs represent a promising new class of nanomaterial-based anticancer agents.

